Noble Financial
http://www.nobleresearch.com/index.htmNoble Financial is a capital markets firm. The firm provides private client services, equity research, sales and trading services, and investment banking services. The sectors in Noble’s coverage universe include healthcare services, media/entertainment, biotechnology, consumer, software, and business services.
View Older Stories View More Recent Stories
-
Noble Financial Downgrades NetScout (NTCT) to Sell
-
Noble Financial Starts Salem Communications (SALM) at Buy
-
Noble Financial Upgrades Nexstar Broadcasting Group (NXST) to Buy
-
Noble Financial Cuts PT on PharmAthene (PIP) to $6; Comments on Recent Court Ruling
-
Noble Financial Remains Bullish on PharmAthene (PIP) Following Court Memo Opinon on Tecovirimat
-
Streetinsider.com's Hot Lunchtime Reads 08/08: (LEAF) (MSFT) (MDVN) (XCO) (CMLS)
-
Noble Financial Downgrades Hanger Orthopedic Group (HGR) to Hold
-
Noble Financial Upgrades Virtusa (VRTU) to Buy
-
Noble Cuts PT on Hutchinson Tech (HTCH) to $3.93 Following Q2 Results; Shares Still Undervalued
-
Notable Analyst Rating Changes 08/01: (EXPE) (DATA) (PCYC) Upgraded; (DDD) (BBBY) (GALT) Downgraded
-
Noble Financial Starts Paramount Gold and Silver (PZG) at Buy
-
Noble Financial Upgrades FEI Company (FEIC) to Hold
-
Noble Financial Upgrades Veeco Instruments Inc. (VECO) to Hold
-
TherapeuticsMD (TXMD) Prices 8.6M Offering at $4.67/Share
-
La Jolla Pharma (LJPC) Poised to Open Lower After 5.4M Offering Prices at $10.50/Share
-
La Jolla Pharmaceutical (LJPC) Prices 4.8M Common Offering at $10.50/Share
-
Unusual 11 Mid-Day Movers 07/15: (CDXS) (MEA) (PLUG) Higher; (OPTT) (NERV) (FHCO) Lower
-
Noble Financial Comments on GreenHunter Resources (GRH) Following 29% Run Higher
-
Noble Financial Maintains ;Buy' Rating on Ultratech (UTEK); Addresses Quals of Flash, Laser Anneal Concerns
-
Noble Financial Lifts PT on La Jolla Pharma (LJPC) to $38
-
Noble Financial Keeps Harte-Hanks (HHS) at 'Buy'; Thinks Trillium Could be Worth Way More than Previously Expected
-
Noble Financial Positive on PharMerica's (PMC) Following Altius Healthcare Acquisition
-
Pre-Open Stock Movers 6/30: (MNKD) (DRNA) (BK) Higher; (APP) (MBI) (WLT) Lower (more...)
-
Noble Financial Upgrades Ultratech (UTEK) to Buy
-
Noble Financial Trims Outlook on CACI Int'l (CACI) Following FY15 Outlook
-
Heron Therapeutics (HRTX) Prices 4.5M Offering at $11.75/sh
-
Noble Financial Downgrades MICROS Systems (MCRS) to Hold
-
Noble Financial Starts Engility Holdings, Inc. (EGL) at Buy
-
Noble Financial Positive on Healthways (HWAY) Following New Partnership with Physicians Group
-
Noble Financial Positive on TherapeuticsMD (TXMD) Following Investor Day
-
Noble Financial Lifts PT on BioCryst (BCRX) to $19 Following BCX4161 Phase 2a Data
-
Streetinsider.com's Hot Lunchtime Reads 06/17: (MCRS) (YHOO) (PTEN) (BSX)
-
European Prospects Could Broaden Virtusa's (VRTU) Opportunity - Noble Financial
-
Noble Financial Boosts PT on GreenHunter Resources (GRH) to $2.25
-
Streetinsider.com's Hot Lunchtime Reads 06/10: (AAPL) (ACHN) (CCJ) (GALE)
-
Noble Financial Comments on Galena Biopharma's (GALE) FBP Vaccine Presentation at ASCO
-
Noble Boosts PT on Comtech Telecom (CMTL) to $38; Notes Additional Buybacks
-
BioCryst Announces Exercise of Over-Allotment Option and Completion of Public Offering
-
Noble Keeps Martha Stewart Living (MSO) at 'Buy'; Management is Picking Up the Pace
-
Noble Financial Starts GreenHunter Resources (GRH) at Buy
-
BioCryst Pharmaceuticals Prices Public Offering of Common Stock
-
Noble Financial Maintains 'Hold' Rating on iGATE Corp. (IGTE); Offers Takeaways from Investor and Analyst Day
-
Noble Financial Maintains Gannet (GCI) at 'Buy'; Making Big Moves in Texas
-
Noble Financial Upgrades Callon Petroleum (CPE) to Buy
-
Noble Financial Keeps 'Buy' Rating on Galena Biopharma (GALE) Following Q1 Results
-
Noble Financial Upgrades Martha Stewart Living Omnimedia (MSO) to Buy (Earlier)
-
PetMed (PETS) Momentum Absent Heading into Flea-and-Tick Season - Noble
-
KEYW Holding (KEYW) Unique Story Still Intact Following Q1 Results; Noble Keeps at 'Buy'
-
FEI (FEIC) Still Overvalued Following Q1 Report; Noble Financial Maintains 'Sell' Rating
-
Noble Financial Starts Avino Silver & Gold (ASM) at Buy

